School of Medicine
Showing 1-2 of 2 Results
-
Mausam Kalita
Temp - Non-Exempt, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordSenior Research Scientist:
1) cold chemical synthesis— Synthesis of the 12C and 19F- HPLC standards and precursors for 11C- and 18F- labeling
2) radiosynthesis— Introduction of 11C or 18F radioisotopes into small molecules to develop novel PET tracers, that can track activated myeloid cells in neurodegenerative diseases
3) radiometal labeling— 64Cu and 89Zr labeling of monoclonal antibodies that target immune receptors
4) clinical translation— To follow FDA guidelines for translating preclinically validated tracers into humans in the cyclotron and radiochemistry facility (CRF) of the Stanford University -
Jeffrey Howard Kleck
Adjunct Professor, Rad/Molecular Imaging Program at Stanford
BioJeff is an Adjunct Professor at Stanford University, and a leader in the Silicon Valley tech venture community. He is an established technology and software entrepreneur having built several ventures from concept to market leader, in which he has served as Founder, CEO, and Chairman. Jeff has taken his ventures public on the NASDAQ and unified them into far-reaching commercial corporations. Jeff has served as a Highly Qualified Expert (HQE) for the United States Government as a Director of the Defense Innovation Unit (DIU) in Mountain View, California where he was responsible for delivering transformational and strategic capabilities to the military and for strengthening the national security innovation base by accelerating the adoption of commercial technology. Jeff has participated as a visiting scientist at two national laboratories, and holds a PhD in Biomedical Physics from UCLA (former faculty); an MS in Engineering Management from Stanford University (current faculty); and, an MS and a BS in Nuclear Engineering from Texas A&M University.